Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer (Q73690540)
scientific article published on 01 September 1997
Language:
(P31) (Q13442814)
(P50) (Q89754678)
(P304) 3156-3163
(P407) (Q1860)
(P433) 9
(P478) 15
(P577) Monday, September 1, 1997
Monday, September 1, 1997
(P921) (Q42824440)
(Q181257)
(Q423762)
(P953) http://intl.jco.org/cgi/content/abstract/15/9/3156
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1997.15.9.3156
(P1433) (Q400292)
(P1476) "Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer" (language: en)
(P2093) G. R. Hudes
F. Nathan
C. Khater
N. Haas
M. Cornfield
B. Giantonio
R. Greenberg
L. Gomella
S. Litwin
S. Roethke
C. McAleer
other details
description scientific article published on 01 September 1997

External Links